Stimulus | Carrier type | Payload | Reference |
---|---|---|---|
pH | PPADK | Dexamethasone | [45] |
 | DMAEMA/HEMA | Paclitaxel | [3] |
 | PC/DAP liposomes | siRNA | [51] |
Temperature | PNIPAm/PLGA | Paclitaxel | [36] |
 | MPPC/DPPC/HSPC/DSPEC-PEG-2000 | Doxorubicin | [54] |
 | FA/PDMA/PNIPAm | Dipyridamole | [57] |
Light | Cu chlorophyllin/PNIPAm | None reported | [60] |
 | Quinone-methide | Nile Red | [63] |
 | Au/meso porous silica | Paclitaxel | [61] |
Ultrasound | Pluronic P105/N,N-diethylacrylamide | Doxorubicin | [66] |
 | DPPC:DPPE-PEG2000 liposomes | Calcein | [67] |
Glucose | poly(methacrylic acid-g-ethylene glycol) with glucose oxidase, PNIPAm with phenylboronic acid | Insulin | |
 | PNIPAm or carboxymethyl dextran with con. A | None reported | |
Enzyme | PEG diacrylate/human neutrophil elastase-sensitive peptide | None reported | [75] |
 | Fibrin/β-nerve growth factor fusion proteins | β-nerve growth factor | [76] |
 | sPLA2-degradable retinoid lipid pro-drug | Retinoid lipid pro-drug | [77] |
Magnetic | Magnetite | Squalenoyl gemcitabine (SQdFdC) | [78] |
 | Poly[aniline-co-N-(1-one-butyric acid)] aniline (SPAnH)/iron oxide | Epirubicin | [79] |
 | Polylactide/nanocrystalline magnetite | Paclitaxel | [80] |
 | Egg-PC/maghemite/PAH/PSS | Calcein | [81] |